Enoxaparina Rovi

Enoxaparin Sodium is an anticoagulant medication used to prevent and treat blood clots. It works by thinning the blood to reduce clotting risks during medical procedures or conditions like haemodialysis.

Enoxaparin Sodium is primarily used to prevent and treat blood clots in various medical settings. It is often administered during haemodialysis to maintain blood flow and reduce clotting in the dialysis circuit. This medication is also used to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients undergoing surgery or those who are bedridden. Enoxaparin Sodium is sometimes prescribed for intravenous or subcutaneous use, depending on the specific medical needs of the patient.

Common effects of Enoxaparin Sodium may include bruising, bleeding, and pain at the injection site. Some users might experience nausea, headache, or dizziness. Severe allergic reactions are rare but can occur, and immediate medical attention is advised if symptoms such as rash, itching, or difficulty breathing are observed.

Enoxaparin Sodium should be handled with care to avoid contamination and ensure proper dosage. It is essential to follow the healthcare provider's instructions for administration, whether intravenous or subcutaneous. Patients with a history of bleeding disorders or recent surgery should inform their healthcare provider before using this medication. Proper storage conditions, such as keeping the medication at room temperature, should be maintained to preserve its efficacy.

Enoxaparin Sodium may interact with other medications that affect blood clotting, such as aspirin, warfarin, or nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be limited, as it can increase the risk of bleeding. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. CYP inhibitors and other blood-thinning agents should be used cautiously in conjunction with Enoxaparin Sodium.